Stage IV Renal Pelvis and Ureter Cancer AJCC v8
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB08875 | Cabozantinib | 1 | Active Not Recruiting | 1 |
| DB06186 | Ipilimumab | 1 | Active Not Recruiting | 1 |
| DB09035 | Nivolumab | 1 | Active Not Recruiting | 1 |
| DB00441 | Gemcitabine | 2 | Terminated | 1 |
| DB11945 | Avelumab | 3 | Active Not Recruiting | 1 |
| DB08875 | Cabozantinib | 3 | Active Not Recruiting | 1 |
| DB01248 | Docetaxel | 3 | Recruiting | 1 |
| DB08871 | Eribulin | 3 | Recruiting | 1 |
| DB00441 | Gemcitabine | 3 | Recruiting | 1 |
| DB01229 | Paclitaxel | 3 | Recruiting | 1 |
| DB12893 | Sacituzumab govitecan | 3 | Recruiting | 1 |